Jiangsu Hengrui Medicine buys back A-shares for employee stock plan

Jiangsu Hengrui Medicine Co., Ltd. announced on October 14, 2025, a buyback of 200,000 A-shares. These shares will be held as treasury stock for an A-share employee stock ownership plan. The transaction took place on the Shanghai Stock Exchange, with the shares acquired at an aggregate cost of RMB 13,066,300. The average buyback price per share ranged from a high of RMB 67 to a low of RMB 64.

Following this buyback, the company's total issued shares (excluding treasury stock) decreased by 200,000, from 6,364,891,264 to 6,364,691,264. Concurrently, the number of treasury shares increased by 200,000, moving from 14,111,010 to 14,311,010. This adjustment maintains the total number of issued shares at 6,379,002,274. The buyback represents approximately 0.0031% of the company's existing issued share capital (excluding treasury stock) prior to the event.

The company affirmed that this buyback was conducted in accordance with the relevant regulations governing share repurchases on the Shanghai Stock Exchange. All necessary conditions and regulatory requirements for the share issuance and transfer were met.